MORRISTOWN, N.J., July 6, 2015 /PRNewswire/ -- Moerae Matrix, a clinical stage biotechnology company focused on developing novel therapeutics that target inflammation and fibrosis, today announced the appointment of Bill Bradford, M.D., PhD, as Chief Medical Officer. Dr. Bradford will...